NLRP3 and Parkinson disease: To this end, beyond addressing our knowledge gaps concerning the intricate role of neuroinflammation in PD pathogenesis, the present study also aimed to provide a potential disease‐modifying strategy by targeting microglial NLRP3 in the SNc to treat PD.